These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3003434)

  • 1. The hypotensive effect of 2-(5-chloro-2-phenoxyanilino)-2-imidazoline (FR35447).
    Kamitani T; Katamoto M; Tsujioka K; Terai T; Ohtsuka M; Ono T; Kikuchi H; Kumada S
    Jpn J Pharmacol; 1985 Oct; 39(2):251-61. PubMed ID: 3003434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of FR35447 on experimental cerebral infarction.
    Kamitani T; Katsuta K; Sakai S; Sakata Y; Motoyama Y; Horiai H; Ono T; Kikuchi H; Kumada S
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):264-76. PubMed ID: 6441533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
    Constantine JW; Lebel W; Weeks R
    J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral cardiovascular alpha- and beta-adrenergic effects of some hypotensive and bradycardic arylalkyl imidazole derivatives in the rat.
    Savola JM; Puurunen J; Ruskoaho H; Kärki NT
    J Pharm Pharmacol; 1985 Jun; 37(6):410-4. PubMed ID: 2862264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo.
    Drew GM; Whiting SB
    Br J Pharmacol; 1979 Oct; 67(2):207-15. PubMed ID: 40647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations into the mechanism of the antihypertensive effect of SGB-1534, a novel alpha 1-adrenoceptor antagonist, in rats.
    Aono J; Sakai K
    Jpn J Pharmacol; 1988 Oct; 48(2):229-39. PubMed ID: 2905394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacology.
    Ryan MJ; Bjork FA; Cohen DM; Coughenour LL; Major TC; Mathias NP; Mertz TE; Olszewski BJ; Singer RM; Evans DB
    J Pharmacol Exp Ther; 1986 Aug; 238(2):473-9. PubMed ID: 2874210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and postsynaptic alpha-adrenergic effects of the antihypertensive drug budralazine.
    Shibamura S; Chiba T; Suzuki I; Akashi A
    Arzneimittelforschung; 1981; 31(7):1076-9. PubMed ID: 6268123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.
    Vayssettes-Courchay C; Bouysset F; Cordi AA; Laubie M; Verbeuren TJ
    Br J Pharmacol; 1996 Feb; 117(3):587-593. PubMed ID: 8821553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
    Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
    J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial pressure, and heart rate in experimental animals.
    Kellar KJ; Quest JA; Spera AC; Buller A; Conforti A; Dias Souza J; Gillis RA
    Am J Med; 1984 Oct; 77(4A):87-95. PubMed ID: 6091452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR-14134, a new benzothiazepine with central hypotensive action.
    Prieto P; Carrón R; Montero MJ; Morán A; Román LS
    Pharmacology; 1995 Aug; 51(2):84-95. PubMed ID: 8584576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the hypotensive action of prazosin.
    Oates HF; Graham RM; Stokes GS
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):41-8. PubMed ID: 901072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats.
    Gardiner SM; Bennett T
    Br J Pharmacol; 1988 Jan; 93(1):9-22. PubMed ID: 2894880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
    Honda K; Takenaka T; Shiono K; Miyata-Osawa A; Nakagawa C
    Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluation of the selectivity of 2-N,N-dimethylamino-5,6-dihydroxy-1,2,3, 4-tetrahydronaphthalene (M-7) as an agonist of postjunctional alpha-2 adrenoceptors in the pithed normotensive rat.
    Timmermans PB; Wilffert B; Davidesko D; Mathy MJ; Dijkstra D; Horn AS; van Zwieten PA
    J Pharmacol Exp Ther; 1983 May; 225(2):407-9. PubMed ID: 6132992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of R 28935- and R 29814-induced hypotension by prazosin in anaesthetized normotensive rats.
    Timmermans PB; Slothorst-Grisdijk FP; Kwa HY; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):309-20. PubMed ID: 7073408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.